Vaxart (VXRT): Great Potential But Issues Remain

Mutating Virus Variant

wildpixel

Isn’t it a bit unnerving that doctors call what they do “practice”?”― George Carlin

We posted our first and only take on unique vaccine developer Vaxart Inc. (NASDAQ:VXRT) in June of this year. We concluded that piece with this

Stock Chart

Seeking Alpha

Vaxart - Investor Presentation 07 29 2022

Company Website

Addressable Covid Market

January Company Presentation

Be the first to comment

Leave a Reply

Your email address will not be published.


*